⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7100012 | 0.79 | — | — | |
| SCHEMBL11298288 | 0.79 | MEN1 (0.32) | — | |
| SCHEMBL3688307 | 0.79 | — | — | |
| SCHEMBL25218451 | 0.77 | — | — | |
| SCHEMBL15539713 | 0.77 | — | — | |
| SCHEMBL148930 | 0.72 | MEN1 (0.47) | — | |
| SCHEMBL132519 | 0.72 | MEN1 (0.38) | — | |
| SCHEMBL6995759 | 0.72 | — | — | |
| SCHEMBL9152702 | 0.72 | MEN1 (0.32) | — | |
| SCHEMBL5072125 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1016711-B1 | Process for inactivating enveloped viruses in a viral composition containing adenoviruses | TRANSGENE SA (FR) | 2004-10-27 | — | — | EP | disclosed |
| EP-1155120-A1 | METHOD FOR OBTAINING A PURIFIED VIRAL PREPARATION | TRANSGENE S.A. (FR) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000050573-A1 | METHOD FOR OBTAINING A PURIFIED VIRAL PREPARATION | TRANSGENE S.A. (FR) | 2000-08-31 | — | — | WO | disclosed |
| EP-1016711-A1 | Process for inactivating enveloped viruses in a viral preparation containing non-enveloped viruses | TRANSGENE S.A. (FR) | 2000-07-05 | — | — | EP | disclosed |